Baxter International (BAX) Operating Expenses (2009 - 2026)

Baxter International (BAX) has 18 years of Operating Expenses data on file, last reported at $867.0 million in Q1 2026.

• Quarterly Operating Expenses rose 2.85% year-over-year to $867.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $867.0 million (up 2.85% YoY) and the FY2025 annual result came in at $3.4 billion, down 4.19% from the prior year.
• Operating Expenses advanced to $867.0 million in Q1 2026 per BAX's latest filing, from $843.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $1.2 billion in Q1 2024 and bottomed at $15.0 million in Q4 2023.
• The 5-year median for Operating Expenses is $1.1 billion (2022), against an average of $903.4 million.
• The widest annual swing landed in 2022, when Operating Expenses soared 59.21%; it then slumped 89.36% in 2023.
• Tracing BAX's Operating Expenses over 5 years: stood at $141.0 million in 2022, then tumbled by 89.36% to $15.0 million in 2023, then surged by 7920.0% to $1.2 billion in 2024, then slipped by 29.93% to $843.0 million in 2025, then grew by 2.85% to $867.0 million in 2026.
• Per Business Quant, the three latest BAX Operating Expenses figures stand at $867.0 million (Q1 2026), $843.0 million (Q1 2025), and $1.2 billion (Q1 2024).

Peer Comparison